ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 7 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $798 | -20.2% | 2,217 | +38.6% | 0.00% | – |
| Q3 2022 | $1,000 | -83.3% | 1,600 | -74.9% | 0.00% | – |
| Q1 2022 | $6,000 | -71.4% | 6,369 | -46.0% | 0.00% | – |
| Q3 2021 | $21,000 | +50.0% | 11,793 | +176.6% | 0.00% | – |
| Q2 2021 | $14,000 | +600.0% | 4,264 | +616.6% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 595 | -52.2% | 0.00% | – |
| Q4 2020 | $2,000 | -33.3% | 1,246 | -16.8% | 0.00% | – |
| Q2 2020 | $3,000 | -25.0% | 1,498 | -62.4% | 0.00% | – |
| Q1 2020 | $4,000 | – | 3,984 | +2556.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 150 | -96.3% | 0.00% | – |
| Q3 2019 | $7,000 | -22.2% | 4,077 | +39.8% | 0.00% | – |
| Q2 2019 | $9,000 | -35.7% | 2,917 | -13.5% | 0.00% | – |
| Q1 2019 | $14,000 | 0.0% | 3,374 | -10.4% | 0.00% | – |
| Q4 2018 | $14,000 | – | 3,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,017,971 | $2,066,000 | 0.49% |
| DAFNA Capital Management LLC | 117,682 | $239,000 | 0.08% |
| Temasek Holdings (Private) Ltd | 1,422,475 | $2,888,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 415,450 | $843,000 | 0.02% |
| Virtu Financial LLC | 54,386 | $110,000 | 0.01% |
| MARSHALL WACE, LLP | 96,095 | $195,000 | 0.00% |
| UBS Group AG | 150 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 2,151 | $4,000 | 0.00% |
| MORGAN STANLEY | 18,582 | $37,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 10,000 | $20,000 | 0.00% |